# OnCo record sr-one (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/sr-one/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "sr-one" ;
  schema:name "SR One"@en ;
  schema:description "SR One is a transatlantic biotech venture firm that began as GSK's corporate venture arm and now invests independently from London and the US West Coast. Oncology accounts for a large share of its portfolio, including Akamis Bio (gene-based immunotherapy), Avenzo Therapeutics, Charm Therapeutics (menin inhibitors for acute myeloid leukaemia) and Biotheryx (protein degradation)."@en ;
  schema:url <https://onco.cc/companies/sr-one/>, <https://www.srone.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.srone.com/>, <https://www.srone.com/portfolio> ;
  onco:tag "vc" ;
  schema:addressCountry "GB" ;
  onco:companies <https://onco.cc/companies/gsk/>, <https://onco.cc/companies/avenzo/> .